BMC Biotechnology

Section Editors

Joaquim M Cabral, Instituto Superior Tecnico
Dhinakar S Kompala, University of Colorado
Lluis Montoliu, Centro Nacional de Biotecnologia
Mats Nilsson, Uppsala University
Peter J Punt, TNO Quality of Life
Marko Radic, University of Tennessee
John J Rossi, Beckman Research Institute City of Hope
Igor Stagljar, University of Toronto
C Neal Stewart, University of Tennessee

Executive Editor

Christopher Morrey, Biomed Central

Editorial Board | Editorial Team | Instructions for authors | FAQ

Articles

There has been an error retrieving the data. Please try again.

Brightest reporter in transgenic plants

The tandem dimer tdTomato and the monomeric mOrange are the two highest fluorescing orange fluorescent proteins (OFPs) available as reporters for transgenic plants, when targeted to the endoplasmic reticulum.

BMC Biotechnology 2012, 12:17
Novel technique for GMO detection

Genetically modified maize DNA can be effectively detected even at low levels of contamination by the coupling of loop mediated isothermal amplification (LAMP) to a bioluminescent output produced in real-time (BART).

BMC Biotechnology 2012, 12:15
Monitoring intra-particle pH

A Dual-Lifetime Referencing (DLR) method based on the luminophores fluorescein and Ru(dpp) allows the measurement of pH within the particles of carrier-bound immobilized enzymes and has potential as an analytical tool in biocatalysis.

BMC Biotechnology 2012, 12:11
Engineered T cells against leukemia

Marko Radic discusses recent advances in cancer immunotherapy, whereby cytotoxic T cells from patients with leukemia are turned into efficient and specific killers of their own cancer cells.

BMC Biotechnology 2012, 12:6
UV/TMP method for C. elegans manipulation

A method utilizing ultraviolet trimethylpsoralen (UV/TMP) based on familiar extrachromosomal transgenics offers an alternative to Mos1 transposon or microparticle bombardment in the creation of single- or low-copy chromosomal integrated lines of Caenorhabditis elegans.

BMC Biotechnology 2012, 12:1
View more articles

RSS

Comments

Abstract correction

Comment on: Rocha-Martín et al. BMC Biotechnology 2011, 11:101
Correction

Comment on: van der Voet et al. BMC Biotechnology 2011, 11:15
current adress

Comment on: Borejsza-Wysocka et al. BMC Biotechnology 2010, 10:41

RSS

News from the web

10 May 2012: Researchers use light to switch on gene expression

27 April 2012: Research breakthrough for drugs via the skin

25 April 2012: Prions in the brain eliminated by homing molecules

Scope

BMC Biotechnology is an open access, peer-reviewed journal that considers articles on the manipulation of biological macromolecules or organisms for use in experimental procedures, cellular and tissue engineering or in the pharmaceutical, agricultural biotechnology and allied industries.

It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.

RSS

From the blog

14 May 2012: IRCIMH 2012

14 May 2012: Join us at the Royal College of Ophthalmologists Annual Congress

10 May 2012: Interventions given during pregnancy improve outcome for obese women

Quote

"I strongly believe in the internet and open-access publishing in order to achieve scientific outreach both within academia and outside academia. Open-access allows anyone in the world with access to a computer to access scientific research. These innovative journals are becoming extremely successful and will change the nature of scientific publishing and increase the accessibility of science."

Professor Sally Blower
Semel Institute for Neuroscience & Human Behavior,
UCLA David Geffen School of Medicine, USA